Skip to main content

Table 4 The prevalence of the three ECP genotypes in the never-smoking, ex-smoking and smoking random cohorts of Sweden and Estonia

From: Associations of ECP (eosinophil cationic protein)-gene polymorphisms to allergy, asthma, smoke habits and lung function in two Estonian and Swedish sub cohorts of the ECRHS II study

 

Never-smokers

Ex-smokers

Smokers

p-value (χ2-test)

ECP434(G>C)

GG/GC/CC

170/97/9 (62%/35%/3%)

65/80/7 (43%/53%/5%)

96/42/2 (69%/30%/1%)

0.0001

ECP562(G>C)

GG/GC/CC

197/73/6 (71%/26%/2%)

88/60/3 (58%/40%/2%)

109/30/1 (78%/21%/1%)

0.0048

ECP c.-38(A>C)

AA/AC/CC

59/142/75 (21%/51%/27%)

22/85/44 (15%/56%/29%)

33/66/41

(24%/47%/29)

Ns